ABSTRACT: Multiple randomized controlled trials (RCTs) have assessed the effects of supplementation with eicosapentaenoic acid plus docosahexaenoic acid (omega-3 polyunsaturated fatty acids, commonly called fish oils) on the occurrence of clinical cardiovascular diseases. Although the effects of supplementation for the primary prevention of clinical cardiovascular events in the general population have not been examined, RCTs have assessed the role of supplementation in secondary prevention among patients with diabetes mellitus and prediabetes, patients at high risk of cardiovascular disease, and those with prevalent coronary heart disease. In this scientific advisory, we take a clinical approach and focus on common indications for omega-3 polyunsaturated fatty acid supplements related to the prevention of clinical cardiovascular events. We limited the scope of our review to large RCTs of supplementation with major clinical cardiovascular disease end points; meta-analyses were considered secondarily. We discuss the features of available RCTs and provide the rationale for our recommendations. We then use existing American Heart Association criteria to assess the strength of the recommendation and the level of evidence. On the basis of our review of the cumulative evidence from RCTs designed to assess the effect of omega-3 polyunsaturated fatty acid supplementation on clinical cardiovascular events, we update prior recommendations for patients with prevalent coronary heart disease, and we offer recommendations, when data are available, for patients with other clinical indications, including patients with diabetes mellitus and prediabetes and those with high risk of cardiovascular disease, stroke, heart failure, and atrial fibrillation
You are welcome to follow along as I bring myself up to speed on this cutting edge science.
I am looking into carrying CBP oil at my clinic. Here is a reference to some exciting research and the effect this organic oil has on Cancer.
A part of the Dao Te Ching, Lao Tzu speaks on the topic of the three treasures.
I have found this particular lesson is most useful for people of at least 40 years of life experience.
The first treasure is Love. Spend you time doing the things you love to do. If you find yourself spending time doing something you don’t love, then either learn to love it or do something else.
The second treasure is Moderation. Do what you love doing in moderation. Too much of anything causes imbalances in your body and mind and leads to catastrophes.
The third treasure is Humility. This one doesn’t quite translate well. He doesn’t speak of the type of humility like bowing before a greater power. This humility is a reminder that as you become successful in life there will be riches, rewards, admiration, and other things happen. Being humble is keeping focused on doing what you love and not getting lost in the trappings of success.
Remind yourself of these simply truths each day and the reward will be many years of continued happiness and success for you and everyone you can help.
It has been a long while since i used this page to communicate. Facebook has taken most of my time. In 2017 I want to create something a little more lasting than Facebook and will start blogging here again. See you soon.
Corrupt to the core.
“Senator Posey Calls for Investigation of CDC Fraud Senator Posey discusses how Dr. Bill Thompson and his colleagues hid data connecting autism and the MMR vaccine. Then they agreed to destroy all documents related to the study. Correctly believing this was an illegal act, Dr. Thompson kept copies of all documents and data files.”
***THIS IS IMPORTANT***
In this article we report a large-scale chemical screen in adult Drosophila to find inhibitors of stem-cell–derived tumors. To our surprise, we found that some Food and Drug Administration-approved chemotherapy drugs have the dual property of reducing growth of stem-cell–derived tumors while also stimulating hyperproliferation of their wild-type counterparts. Since hyperproliferation is one of the hallmarks of cancer cells, this side effect could contribute to refueling the growth of the very tumors that these chemotherapeutics are intended to inhibit. We show that this side effect is driven by the evolutionarily conserved Janus kinase-signal transducers and activators of transcription (JAK-STAT) inflammatory pathway, raising the possibility that the JAK-STAT pathway may also be activated in humans who are treated with some chemotherapeutics.”
“These results reveal an unanticipated side effect on stem cells that may contribute to tumor recurrence.”